UNBX (Unity Biotechnology) Float Percentage Of Total Shares Outstanding: 98.58% (As of Jul. 05, 2026)


What is Unity Biotechnology Float Percentage Of Total Shares Outstanding?

Unity Biotechnology UNBX Float Percentage Of Total Shares Outstanding is 98.58% as of Jul. 05, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Unity Biotechnology's float shares is 16.97 Mil. Unity Biotechnology's total shares outstanding is 17.21 Mil. Unity Biotechnology's float percentage of total shares outstanding is 98.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Unity Biotechnology's Insider Ownership is 11.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Unity Biotechnology's Institutional Ownership is 0.17%.

Unity Biotechnology Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Unity Biotechnology's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=16.97/17.21
=98.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 98.58% mean?
Unity Biotechnology (UNBX) has a Float Percentage Of Total Shares Outstanding of 98.58% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Unity Biotechnology and its competitors.
Is Unity Biotechnology's Float Percentage Of Total Shares Outstanding too high?
Unity Biotechnology's current Float Percentage Of Total Shares Outstanding is 98.58%.
How does Unity Biotechnology's Float Percentage Of Total Shares Outstanding compare to ADTX and HEPA?
Unity Biotechnology's Float Percentage Of Total Shares Outstanding of 98.58% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Unity Biotechnology and its competitors. Unity Biotechnology's current Float Percentage Of Total Shares Outstanding is 98.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unity Biotechnology stock overvalued right now?
Unity Biotechnology (UNBX) has a current Float Percentage Of Total Shares Outstanding of 98.58%. The current Float Percentage Of Total Shares Outstanding is 98.58%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Unity Biotechnology (UNBX), the current Float Percentage Of Total Shares Outstanding is 98.58% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Unity Biotechnology Business Description

Address 285 East Grand Avenue, South San Francisco, CA, USA, 94080
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.